A Quarterly Webinar Series for Patients and Families Join Kevin Flanigan, MD, and his guests for What’s New in Muscular Dystrophy?, a webinar series that highlights the latest in basic and clinical research at Nationwide Children’s Hospital. Learn about new and exciting findings and what this work might mean for the treatment of muscular dystrophies and other inherited neuromuscular disorders.
Saturday, March 27, 2021 (2 p.m.): “Preclinical development of vectorized exon 44 skipping” featuring Dr. Nicolas Wein
Featured Speaker Nicolas Wein, PhD Principal Investigator, Center for Gene Therapy Nicolas Wein, PhD, is a principal investigator in the Center for Gene Therapy in the Abigail Wexner Research Institute at Nationwide Children’s Hospital and an assistant professor of Pediatrics at The Ohio State University College of Medicine. Dr. Wein and his lab in study neuromuscular disorders, particularly Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1), to understand their causes and develop innovative treatments.
Register to JoinFirst Name
Last Name
A Quarterly Webinar Series for Patients and Families Join Kevin Flanigan, MD, and his guests for What’s New in Muscular Dystrophy?, a webinar series that highlights the latest in basic and clinical research at Nationwide Children’s Hospital. Learn about new and exciting findings and what this work might mean for the treatment of muscular dystrophies and other inherited neuromuscular disorders.
Saturday, March 27, 2021 (2 p.m.): “Preclinical development of vectorized exon 44 skipping” featuring Dr. Nicolas Wein
Featured Speaker Nicolas Wein, PhD Principal Investigator, Center for Gene Therapy Nicolas Wein, PhD, is a principal investigator in the Center for Gene Therapy in the Abigail Wexner Research Institute at Nationwide Children’s Hospital and an assistant professor of Pediatrics at The Ohio State University College of Medicine. Dr. Wein and his lab in study neuromuscular disorders, particularly Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1), to understand their causes and develop innovative treatments.
Register to JoinFirst Name
Last Name
A Quarterly Webinar Series for Patients and Families Join Kevin Flanigan, MD, and his guests for What’s New in Muscular Dystrophy?, a webinar series that highlights the latest in basic and clinical research at Nationwide Children’s Hospital. Learn about new and exciting findings and what this work might mean for the treatment of muscular dystrophies and other inherited neuromuscular disorders.
A Quarterly Webinar Series for Patients and Families
Join Kevin Flanigan, MD, and his guests for What’s New in Muscular Dystrophy?, a webinar series that highlights the latest in basic and clinical research at Nationwide Children’s Hospital. Learn about new and exciting findings and what this work might mean for the treatment of muscular dystrophies and other inherited neuromuscular disorders.
Saturday, March 27, 2021 (2 p.m.): “Preclinical development of vectorized exon 44 skipping” featuring Dr. Nicolas Wein
Featured Speaker Nicolas Wein, PhD Principal Investigator, Center for Gene Therapy Nicolas Wein, PhD, is a principal investigator in the Center for Gene Therapy in the Abigail Wexner Research Institute at Nationwide Children’s Hospital and an assistant professor of Pediatrics at The Ohio State University College of Medicine. Dr. Wein and his lab in study neuromuscular disorders, particularly Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1), to understand their causes and develop innovative treatments.
Saturday, March 27, 2021 (2 p.m.): “Preclinical development of vectorized exon 44 skipping” featuring Dr. Nicolas Wein
Featured Speaker Nicolas Wein, PhD Principal Investigator, Center for Gene Therapy Nicolas Wein, PhD, is a principal investigator in the Center for Gene Therapy in the Abigail Wexner Research Institute at Nationwide Children’s Hospital and an assistant professor of Pediatrics at The Ohio State University College of Medicine. Dr. Wein and his lab in study neuromuscular disorders, particularly Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1), to understand their causes and develop innovative treatments.
Saturday, March 27, 2021 (2 p.m.): “Preclinical development of vectorized exon 44 skipping” featuring Dr. Nicolas Wein
Featured Speaker Nicolas Wein, PhD Principal Investigator, Center for Gene Therapy Nicolas Wein, PhD, is a principal investigator in the Center for Gene Therapy in the Abigail Wexner Research Institute at Nationwide Children’s Hospital and an assistant professor of Pediatrics at The Ohio State University College of Medicine. Dr. Wein and his lab in study neuromuscular disorders, particularly Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1), to understand their causes and develop innovative treatments.
Featured Speaker Nicolas Wein, PhD Principal Investigator, Center for Gene Therapy Nicolas Wein, PhD, is a principal investigator in the Center for Gene Therapy in the Abigail Wexner Research Institute at Nationwide Children’s Hospital and an assistant professor of Pediatrics at The Ohio State University College of Medicine. Dr. Wein and his lab in study neuromuscular disorders, particularly Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1), to understand their causes and develop innovative treatments.
Featured Speaker Nicolas Wein, PhD Principal Investigator, Center for Gene Therapy Nicolas Wein, PhD, is a principal investigator in the Center for Gene Therapy in the Abigail Wexner Research Institute at Nationwide Children’s Hospital and an assistant professor of Pediatrics at The Ohio State University College of Medicine. Dr. Wein and his lab in study neuromuscular disorders, particularly Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1), to understand their causes and develop innovative treatments.
Featured Speaker Nicolas Wein, PhD Principal Investigator, Center for Gene Therapy
Nicolas Wein, PhD, is a principal investigator in the Center for Gene Therapy in the Abigail Wexner Research Institute at Nationwide Children’s Hospital and an assistant professor of Pediatrics at The Ohio State University College of Medicine.
Dr. Wein and his lab in study neuromuscular disorders, particularly Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1), to understand their causes and develop innovative treatments.
Register to JoinFirst Name
Last Name
Register to JoinFirst Name
Last Name
